Kopran Ltd.
KOPRAN Share PricePharmaceuticals & Drugs
₹180.3
3.3 (1.8%)
As on September 8, 2025
Exchange Scrips: BSE524280NSEKOPRANISININE082A01010
Market Cap ₹ 875 Cr
P/E Ratio 22.58
Dividend Yield 0.17 %
Performance
Market performance
Open177.98
High185.8
Volumes5,64,732
Prev180.3
Low177
As on2025-09-08
Historical performance
1 Year High369.7
3 Year High369.7
5 Year High370.45
1 Year Low154.06
3 Year Low96
5 Year Low67.05
Fundamentals
Company Valuation
Market Cap (₹Cr)
875
Face Value (₹)
10
P/E Ratio
22.58
Dividend Yield
0.17 %
Investment Returns
1 Year
-46.3%
3 Years
1.5%
5 Years
156.3%
10 Years
308.8%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 171.79 | Bullish |
| 10-DMA | 164.35 | Bullish |
| 20-DMA | 161.75 | Bullish |
| 50-DMA | 169.82 | Bullish |
| 100-DMA | 179.93 | Bullish |
| 200-DMA | 186.82 | Bearish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 17 | 18 | 19 | 20 | 20 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 17 | 18 | 19 | 20 | 20 |
| Public Investors | 60176 | 58633 | 60540 | 57133 | 51472 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 22.58.
- 3Y Stock Price CAGR of the stock is 1.2.
- The stock has a beta of 1.6.
- In the last financial year, the company had an EBITDA of ₹769 Million.
- The company generated revenue of ₹6296 Million in the previous financial year.
Kopran Ltd.
180.33.3 (1.8%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 520872.5
No. of Shares: 2889 (Approx)
Performance:-47.9%
P/L: ₹-479127.5
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent